Trelagliptin Succinate CAS 1029877-94-8

Trelagliptin Succinate CAS 1029877-94-8

CAS NO: 1029877-94-8
Molecular Formula: C22H26FN5O6
Molecular Weight: 475.47
MDL NO: MFCD22665720
Chat Now

Product Details

Product Description:

Product Name: Trelagliptin succinate CAS NO:1029877-94-8




(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile succinate;


Chemical & Physical Properties:

Appearance : White to off-white powder

Assay :≥99.0%


Trelagliptin Succinate, developed by Takeda, Japan, was marketed in March 2015 under the trade name Zafatek, used for the treatment of type 2 diabetes. Troxagliptin is an ultra-long-acting dipeptidyl peptidase IV (DPP-4) inhibitor by selectively and continuously inhibiting DPP-4 to control blood sugar levels. Traxagliptin is the world’s first oral once-a-week hypoglycemic drug, and similar DPP-4 inhibitors on the market need to be taken orally once a day. Zafatek’s advantages will undoubtedly provide a more convenient treatment option for diabetic patients. , It is expected to greatly improve the convenience and compliance of patients.


If you are interested in our products or have any questions, please feel free to contact us!



Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.




Hot Tags: trelagliptin succinate cas 1029877-94-8, manufacturers, suppliers, factory, buy, in stock, Fine Chemicals, 2-(4-Bromomethyl)phenylpropionic Acid, 4-Bromomethyl-2-cyanobiphenyl, CAS 249289-10-9, 5-[ethyl(2-hydroxyethyl)amino]pentan-2-one, CAS NO 4212-49-1


You Might Also Like